Abstract
Research into the aetiological agent of the most widespread form of severe malaria,
Plasmodium falciparum
, has benefitted enormously from the ability to culture and genetically manipulate blood-stage forms of the parasite in vitro. However, most malaria outside Africa is caused by a distinct
Plasmodium
species,
Plasmodium vivax
, and it has become increasingly apparent that zoonotic infection by the closely related simian parasite
Plasmodium knowlesi
is a frequent cause of life-threatening malaria in regions of southeast Asia. Neither of these important malarial species can be cultured in human cells in vitro, requiring access to primates with the associated ethical and practical constraints. We report the successful adaptation of
P. knowlesi
to continuous culture in human erythrocytes. Human-adapted
P. knowlesi
clones maintain their capacity to replicate in monkey erythrocytes and can be genetically modified with unprecedented efficiency, providing an important and unique model for studying conserved aspects of malarial biology as well as species-specific features of an emerging pathogen.